Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes.
Semaglutide use was associated with fewer TED-related diagnoses and treatments over 5 years, supporting a potential protective role. Further studies are warranted to confirm these associations and clarify underlying mechanisms.
Authors
- Rena Pollack (ORCID: https://orcid.org/0000-0001-6771-337X)
- Zvi Gur
- Ofira Zloto (ORCID: https://orcid.org/0000-0002-3548-424X)
- Tehila Shlomov
- Itay Nitzan (ORCID: https://orcid.org/0000-0001-6925-5157)
Institutions
- Hebrew University of Jerusalem (IL)
- Sheba Medical Center (IL)
- Hadassah Medical Center (IL)
Publication Details
- Journal
- PubMed
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1016/j.jcjo.2026.01.010
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00